StockWatch
·

Pharma & Healthcare · Q1 FY27 results

final · 257 of 258 results

Very Good42Good67Steady37Weak77Poor28Not rated yet6
Reported

257

of 258 results

Rated positive

43%

very good + good, of 251 rated

Profit growth

+15.8%

median YoY, n=189

Day-1 move

-0.8%

median, n=247

Numbers

Pharma & Healthcare · Q1 FY27 · growth year on year
Year on yearAggregateMedianN
Revenue+17.2%+17.0%227
Net profit+6.5%+15.8%189
Day-1 move—-0.8%247

Profit up at 119 of 189 (63.0%) · growing faster than 15%: 101 (53.4%) · Median excludes extremes: revenue 0, profit 5

Reports

Reaction

Median day-1 move 0.8% · 100 up, 141 down of 247 priced

How these numbers are made

StockWatch Result Rating is our own rating of the reported quarter, not of the stock; counts are of quarters rated so far.

Growth: year-on-year vs the same quarter of Q1 FY26, one basis per company (consolidated where both years report it, else standalone); banks, financial services and insurers by total income. Aggregate = growth of the summed values; median = the middle company. A company whose prior-year profit was a loss has no profit growth figure.

Day-1 reaction = the stock's move on the first session after the result, % vs the last close before it; medians are over quarters with a priced reaction.

Sectors are the 13 StockWatch groups; 365 quarters (diversified or unclassified companies) count in the totals but in no sector.

Size bands by market-cap rank across all listed companies we track: large = top 100, mid = 101-250, small = the rest.

Updated 14 Oct 2026, 05:00 am